SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 65.37 |
| Enterprise Value ($M) | 96.79 |
| Book Value ($M) | 28.67 |
| Book Value / Share | 1.86 |
| Price / Book | 2.28 |
| NCAV ($M) | -18.77 |
| NCAV / Share | -1.22 |
| Price / NCAV | -3.48 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.15 |
| Return on Assets (ROA) | -0.34 |
| Return on Equity (ROE) | -0.82 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.85 |
| Current Ratio | 0.85 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 35.00 |
| Assets | 82.44 |
| Liabilities | 53.77 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 12.53 |
| Operating Income | -7.56 |
| Net Income | -6.25 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 1.78 |
| Cash from Investing | 5.85 |
| Cash from Financing | 6.09 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 134,181 | 502,510 | 26.70 | |
| 61,961 | 176,686 | 35.07 | |
| 9,904 | 40,300 | 24.58 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ALBT – Avalon GloboCare Corp. | ALDX – Aldeyra Therapeutics, Inc. |
| ALGS – Aligos Therapeutics, Inc. | ALZN – Alzamend Neuro, Inc. |
| ANEB – Anebulo Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io